Alvotech Prices $152M Public Offering and Concurrent Private Placement
Summary
Alvotech has priced a $152 million public offering of ordinary shares and a concurrent private placement. This follows previous announcements of a proposed $125 million offering, indicating an increased capital raise. The offering is substantial relative to the company's market capitalization, which will result in significant dilution for existing shareholders.
At the time of this announcement, ALVO was trading at $3.91 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $2.94 to $9.94. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.